In vitro, thymoquinone in renal cell cancer lines (ACHN &786‐O) of xenograft model markedly suppressed the metastatic capacity through AMPK/mTOR signaling pathway, inhibited the migration and invasion, induced autophagy, and suppressed the EMT dose‐dependently (Zhang et al., 2018). Here, MTOR is linked to renal cell adenocarcinoma.